Who we are

Celesio UK is a leading provider of integrated healthcare services to the NHS specialising in medicines, pharmaceutical care and primary care patient services.

With almost 25,000 employees, more than 1,750 community pharmacies, a UK-wide logistics network and dispensing in excess of 150 million items a year, Celesio UK works in partnership with the NHS, community pharmacies and medicines manufacturers to help UK citizens live longer, healthier and more positive lives. Celesio UK provides customers, the NHS and patients with high levels of service, value, efficiency and innovation.

Celesio UK comprises LloydsPharmacy, AAH Pharmaceuticals, Evolution Homecare, LloydsPharmacy Clinical Homecare, Masta, Online Doctor and Betterlife.

With strong brands and about 37,000 employees, Celesio group is active in 13 European countries (thereof with own operations in ten countries; Celesio manages operations in two countries and participates in a joint venture in one country). Every day, the company serves over 2 million customers – at more than 2,150 pharmacies of its own, at about 300 managed pharmacies and at over 4,500 participants in the brand partnership schemes. With 107 wholesale branches in Europe, Celesio supplies more than 50,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products.

McKesson Corporation, San Francisco, USA, is the majority shareholder in Celesio AG. The company acquired more than 75 percent of Celesio AG shares in February 2014. McKesson provides solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services.

McKesson is a Fortune-500 company and currently ranking #5.